CGT Sourcing Guide 2025: How to Build a Resilient Supply Chain Amid Tariff Pressures

CGT Sourcing Guide 2025: How to Build a Resilient Supply Chain Amid Tariff Pressures By CGT Global

By CGT Global The latest round of U.S. tariffs didn’t just shake up the headlines—it shook the very foundations of global pharma supply chains. And while most of the buzz has focused on traditional drugmakers, let’s be clear: cell and gene therapy manufacturers aren’t sitting this one out. For companies working with high-value, time-sensitive materials…

For More Information

Optimizing Gene and Cell Therapy Research by Starting with Properly Sourced Human Bone Marrow Cells

Using Quality Human Bone Marrow Cells to Optimize Cell and Gene Therapy Research

By: Joanna Wirkus Bone Marrow Cells: Critical Tools Driving Stem Cell and Gene Therapy Innovation Surprisingly safe and well tolerated, the first bone marrow biopsy was performed on the shinbone in 1908 by Italian physician Giovanni Ghedini. Today, bone marrow continues to be an important source of information about the health status of individuals with…

For More Information